Deutsche Bank’s OncoSec Medical Incorporated ONCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-467
Closed -$144K 5609
2018
Q3
$144K Buy
467
+9
+2% +$2.77K ﹤0.01% 4369
2018
Q2
$139K Buy
+458
New +$161K ﹤0.01% 4427
2018
Q1
Sell
-731
Closed -$261K 5743
2017
Q4
$261K Buy
+731
New +$256K ﹤0.01% 3906
2016
Q4
Sell
-163
Closed -$61K 5180
2016
Q3
$61K Buy
+163
New +$62.4K ﹤0.01% 4137

Other funds holding ONCS

Deutsche Bank's ONCS Position: Q4 2018 in Review

Deutsche Bank sold out of OncoSec Medical Incorporated (ONCS) in Q4 2018, closing a stake of 467 shares — an estimated $144K sold.

Deutsche Bank first reported a position in ONCS in Q3 2016 and held it in 4 quarters. The position peaked at $261K in Q4 2017. 33 funds tracked by Wall St. Rank hold ONCS as of Q4 2018.

  • Deutsche Bank reported no remaining OncoSec Medical Incorporated position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 467 OncoSec Medical Incorporated shares in Q4 2018, an estimated $144K.
  • Deutsche Bank first reported a position in OncoSec Medical Incorporated in Q3 2016 and held it in 4 quarters.
  • Deutsche Bank's OncoSec Medical Incorporated position peaked at $261K in Q4 2017.
  • 33 funds tracked by Wall St. Rank held OncoSec Medical Incorporated as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.